CD138CAR-CD137/TCRzeta-expressing T Lymphocytes

T-lymphocytes transduced with a retroviral vector expressing a chimeric antigen receptor (CAR) specific for syndecan-1 (CD138) (CART-138 T cells) coupled to the signaling domain of 4-1BB (CD137), and the zeta chain of the T-cell receptor (TCRzeta), with potential immunomodulating and antineoplastic activities. Upon transfusion, CD138CAR- CD137/TCRzeta -expressing T lymphocytes directs the T-lymphocytes to syndecan-1-expressing tumor cells and induces selective toxicity in those tumor cells. The 4-1BB co-stimulatory molecule signaling domain enhances activation and signaling after recognition of syndecan-1. Syndecan-1, a type 1 transmembrane proteoglycan and tumor associated antigen, is overexpressed in a variety of cancer cells. It plays a key role in the regulation of cell growth, differentiation, and adhesion, and its expression is correlated with poor prognosis. (NCI Thesaurus)

YOU MAY ALSO LIKE

CD134

A protein being studied in the treatment of cancer. Substances that attach to CD134 on the surface of T cells (a type…

CD13 Expressing Cell Count

The determination of the amount of CD13 expressing cells per unit present in a sample.

CD11B Expressing Cell Count

The determination of the amount of the CD11b expressing cells in a sample.

CD11A Expressing Cell Count

The determination of the amount of the CD11a expressing cells in a sample.

CD117

A protein found on the surface of many different types of cells. It binds to a substance called stem cell factor (SCF),…

CD109 wt Allele

Human CD109 wild-type allele is located in the vicinity of 6q13 and is approximately 133 kb in length. This allele, which encodes…